ReviewCancer communications (London, England)2022

Current updates of CRISPR/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management.

Khaled S Allemailem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.